Joe Bolen

Joe Bolen

Verkställande Direktör på
Orna Therapeutics, Inc.
72 år
Health Technology
Consumer Services
Finance

Profil

Joseph B. Bolen is currently Chief Executive Officer at Orna Therapeutics, Inc. starting in 2025 and serves as an Independent Director at Aelin Therapeutics NV.
Formerly, Dr. Bolen was Chief Scientific Officer at PureTech Health Plc from 2016 to 2023, Partner at MPM BioImpact LLC in 2026, President & Chief Scientific Officer at Moderna, Inc. and ModernaTX, Inc., Vice President & Head-Oncologic Diseases at Hoechst Marion Roussel, Inc., Advisor at Robert Wood Johnson Medical School, Scientist at National Institutes of Health, Professor & Member-Graduate Faculty at Princeton University, Member-Scientific Advisory Board at Rutgers State University of New Jersey, Chief Scientific Officer & Head-Oncology Research at Millennium Pharmaceuticals, Inc., Founding Director at DNAX Research, Inc., and Director-Cellular Signaling Department at Bristol-Myers Squibb Pharma Research Labs LLC in 2012.
Education includes undergraduate studies at the University of Nebraska and a doctorate from Kansas State University.

Aktiva positioner av Joe Bolen

FöretagPositionStart
Direktör/Styrelseledamot -
Verkställande Direktör 2025-03-31

Tidigare kända positioner av Joe Bolen

FöretagPositionSlut
Privat kapitalinvesterare 2026-06-01
PURETECH HEALTH PLC Teknisk/Vetenskaplig/F&U Direktör 2023-02-01
MODERNA, INC. President -
Teknisk/Vetenskaplig/F&U Direktör -
DNAX Research, Inc.
Företagsledare/Principal -
Se detaljerna i Joe Bolens erfarenhet

Joe Bolens utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

11

Första gradens relationer

16

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag16

Health Technology

Consumer Services

Finance

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Government

Consumer Services

Health Technology

DNAX Research, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology